Home › Funds › GordonMD Global Investments LP › KYTX
GordonMD Global Investments LP position in KYTX
KYVERNA THERAPEUTICS INC · Health Care
GordonMD Global Investments LP reported holding 4,521,318 shares of KYTX (KYVERNA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$30.7M, representing 18.47% of its reported portfolio and ranking #2 among its reported holdings. GordonMD Global Investments LP has disclosed KYTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GordonMD Global Investments LP's KYTX position evolved
GordonMD Global Investments LP first disclosed a stake in KYTX in Q4 2025 at 4,391,818 shares (US$41.3M). Across 4 filings, GordonMD Global Investments LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,521,318 shares valued at US$30.7M — an increase of 276,500 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 4.39M | $41.28M | New |
| Q1 2026 | 4.24M | $36.63M | Reduce |
| Q2 2026 | 4.24M | $37.82M | Hold |
| Q3 2026 | 4.52M | $30.74M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYTX and 13F data
KYTX (KYVERNA THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in KYTX — the largest reported positions include GILEAD SCIENCES, INC. (US$28.1M), AIGH Capital Management LLC (US$24.8M), Bain Capital Life Sciences Investors, LLC (US$8.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYTX
- GILEAD SCIENCES, INC. 4.13M sh · $28.06M · Q3 2026
- AIGH Capital Management LLC 3.65M sh · $24.82M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 1.31M sh · $8.92M · Q3 2026
- Insight Holdings Group, LLC 989.05K sh · $8.81M · Q2 2026
- MBB PUBLIC MARKETS I LLC 614.48K sh · $5.47M · Q2 2026
- Propel Bio Management, LLC 700.60K sh · $4.76M · Q3 2026
More on GordonMD Global Investments LP
FAQ
How long has GordonMD Global Investments LP held KYTX?
GordonMD Global Investments LP has disclosed KYTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is GordonMD Global Investments LP's current position in KYTX?
As of Q3 2026, GordonMD Global Investments LP holds 4.52M shares of KYTX (KYVERNA THERAPEUTICS INC), valued at $30.74M, representing 18.47% of its reported portfolio and ranking #2.
Has GordonMD Global Investments LP been buying or selling KYTX?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP increased its position in KYTX.
Which other funds hold KYTX?
Other major institutional holders of KYTX include GILEAD SCIENCES, INC., AIGH Capital Management LLC, Bain Capital Life Sciences Investors, LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.